SCHEMBL2230568

SCHEMBL2230568

Cc1ccc2c(c1)ncc1ncccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
KDM4E B2RXH2 1/20 0.48
MAPT P10636 1/20 0.48
HTR1A P08908 2/20 0.47
ADRA1D P25100 2/20 0.47
ADRA1A P35348 2/20 0.47
ADRA1B P35368 2/20 0.47
CHEK1 O14757 1/20 0.42
PARP1 P09874 1/20 0.42
PIM1 P11309 1/20 0.42
RPS6KA3 P51812 1/20 0.42
PSMB5 P28074 1/20 0.40
CYP3A4 P08684 1/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP1B1 Q16678 1/20 0.40
NR4A2 P43354 1/20 0.40
NPC1 O15118 1/20 0.39
HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13915654 0.78 KDM4E (0.62) ALDH1A1KDM4EMAPTHTR1AADRA1D
SCHEMBL29327543 0.77 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTHTR1AADRA1D
SCHEMBL29327547 0.77 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTHTR1AADRA1D
SCHEMBL19007835 0.77 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTHTR1AADRA1D
SCHEMBL2231455 0.76 KDM4E (0.68) ALDH1A1KDM4EMAPTHTR1AADRA1D
SCHEMBL12731938 0.76 MAPT (0.61) ALDH1A1KDM4EMAPTHTR1AADRA1D
SCHEMBL2229954 0.75 KDM4E (0.41) ALDH1A1KDM4EMAPTCYP3A4NR4A2
SCHEMBL3969039 0.75 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTPSMB5CYP1A2
SCHEMBL10259398 0.75 NQO2 (0.47) ALDH1A1KDM4EMAPTHTR1AADRA1D
SCHEMBL2229343 0.74 ADRB2 (0.44) KDM4EMAPTCYP3A4NR4A2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2512478-A1 HOMOGENEOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF Novartis AG (CH) 2012-10-24 EP disclosed
WO-2011084549-A1 HOMOGENEOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF NOVARTIS AG (CH) 2011-07-14 WO disclosed